Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A Florida patient has filed a blood thinner Xarelto lawsuit claiming the drug caused him to suffer an internal bleed.
Plaintiffs Joseph and Jennie G. have filed a lawsuit against Johnson & Johnson and Bayer claiming that the blood thinner Xarelto caused Joseph to develop a serious gastrointestinal and rectal bleed.
They claim that the drug makers knew or should have known that internal bleeding was a possible serious side effect of the drug. The argue the companies should not have marketed the drug as safe and effective, and that they should have warned Joseph and his doctor about the risk associated with the drug.
Joseph and Jennie seek compensation for their injury, and say that Joseph would not have taken the drug had he known that it could cause him serious injury.
According to Joseph and Jennie, Joseph took Xarelto between around May 12, 2018 to May 29, 2018. Allegedly, he suffered a gastrointestinal and rectal bleed on May 23, 2018, which the couple says was caused by his use of Xarelto. Joseph claims that he was physically injured by the drug and the bleed he suffered.
Jennie claims that she suffered loss of consortium as a result of Xarelto, because the injuries Joseph allegedly suffered because of his use of their drug negatively affected their relationship.
According to the blood thinner Xarelto lawsuit, Xarelto is a blood thinner (anticoagulant) used to reduce the risk of blood clots in patients, which also can reduce their risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also allegedly use dot treat Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), to reduce the recurrence of the conditions, and to help patients going through knee and hip replacement surgery avoid these conditions.
Xarelto’s FDA approval was first given for a more restricted list of uses, and then was expanded to include more uses for the drug. However, FDA advisory committee members did express reservations about expanding the drug’s uses.
This drug was introduced as a new generation of blood thinners, and was advertised as a replacement to warfarin. Allegedly, studies into the effectiveness of Xarelto versus warfarin show that Xarelto is more likely to cause an internal bleed than warfarin in some patients.
Additionally, Joseph and Jennie say that Johnson & Johnson and Bayer received FDA approval for Xarelto based on studies that did not accurately represent the safety risks associated with Xarelto.
The blood thinner Xarelto lawsuit argues that Johnson & Johnson and Bayer intentionally misrepresented Xarelto as safer than it was in an attempt to gain FDA approval for the drug and ultimately maximize their profits from the sale of the drug.
The Blood Thinner Xarelto Lawsuit is Case No. 2:19-cv-01605-EEF-MBN, in the U.S. District Court for the Eastern District of Louisiana.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Xarelto attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Xarelto class action lawsuit is best for you. [In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Xarelto Class Action Lawsuit Investigation
If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
PLEASE NOTE: If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client or getting you dropped as a client.
Oops! We could not locate your form.
